Zolunicant
Zolunicant (MM-110) is a potent inhibitor against nicotinic α3β4 receptors with an IC50 of 0.90 μM to combat addiction. Zolunicant can decrease the self-administration of several addictive agents including morphine, methamphetamine, nicotine, and ethanol in rat model. Zolunicant can be studied as a potential research for multiple forms of agent abuse[1]. Zolunicant also reveals a potent leishmanicide effect against Leishmania amazonensis[2].
Product Specifications
CAS Number
188125-42-0
Product Name Alternative
MM-110; (±) -18-Methoxycoronaridine
UNSPSC
12352005
Target
NAChR; Parasite
Type
Reference compound
Related Pathways
Anti-infection; Membrane Transporter/Ion Channel; Neuronal Signaling
Applications
COVID-19-immunoregulation
Field of Research
Infection; Neurological Disease
Assay Protocol
https://www.medchemexpress.com/zolunicant.html
Purity
99.29
Solubility
10 mM in DMSO
Smiles
COC([C@]12[C@@]3([H])[N@@](CCC4=C2NC5=CC=CC=C54)C[C@@](C[C@@H]3CCOC)([H])C1)=O
Molecular Formula
C22H28N2O3
Molecular Weight
368.47
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Leishmania
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Canine Vascular Endothelial cell Growth Factor, VEGF ELISA KIT
